Skip to main content Skip to main navigation menu Skip to site footer

Analysis of vitamin D supplementation impact on carcinoembryonic antigen (CEA) levels in stage I-III colorectal cancer

  • Khalikul Razi ,
  • Agi Satria Putranto ,
  • Wifanto Sadityo Jeo ,
  • Riana Pauline Tamba ,
  • Herqutanto ,


Abstract

Link of Video Abstract: https://youtu.be/Bdcbzy1HDeM

 

Background: Colorectal cancer is a globally prevalent and highly lethal malignancy. While vitamin D supplementation may impact cancer risk, its precise effect remains unclear, especially in patients with early-stage III colorectal cancer. This research aimed to enhance our understanding of the potential advantages of vitamin D in colorectal cancer treatment in Indonesia.

Methods: This study is a randomized controlled clinical trial conducted from September 2022 to November 2023 at Cipto Mangunkusumo Hospital's Surgical Polyclinic (RSCM). Inclusion criteria encompass individuals aged 18 and above, diagnosed with stage I–III colorectal cancer, and without a history of surgical or chemotherapeutic colorectal cancer treatment. Exclusion criteria entail patients with a Karnofsky score below 60%, smokers, individuals with inflammatory bowel disease, and those diagnosed with malignancies other than colorectal carcinoma.

Results: The mean vitamin D level in all subjects before the intervention was 16.66 ± 6.23 ng/mL. The median pre-intervention CEA level stood at 4.70 (min-max 1.30–59.40). There was a notable change in CEA levels within the experimental group (median delta CEA: -0.20), and the response to vitamin D supplementation exhibited variations depending on the degree of cancer cell differentiation.

Conclusion: The outcomes of this study indicate that vitamin D supplementation can significantly reduce CEA levels in patients with stage I-III colorectal cancer who have not received prior medical treatment.

Keywords: colorectal cancer vitamin D CEA stage

References

  1. Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol. 2019;14(2):89–103.
  2. Sawicki T, Ruszkowska M, Danielewicz A, Niedźwiedzka E, Arłukowicz T, Przybyłowicz KE. A review of colorectal cancer in terms of epidemiology, risk factors, development, symptoms and diagnosis. Cancers (Basel). 2021;13(9):2025.
  3. Lotfollahzadeh S, Recio-Boiles A, Cagir B. Colon Cancer. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 [cited 2022 Sep 6]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK470380/
  4. Peus D, Newcomb N, Hofer S. Appraisal of the Karnofsky performance status and proposal of a simple algorithmic system for its evaluation. BMC medical informatics and decision making. 2013; 13(1):1-7.
  5. Boughanem H, Canudas S, Hernandez-Alonso P, Becerra-Tomás N, Babio N, Salas-Salvadó J, et al. Vitamin D intake and the risk of colorectal cancer: An updated meta-analysis and systematic review of case-control and prospective cohort studies. Cancers (Basel). 2021;13(11):2814.
  6. Klampfer L. Vitamin D and colon cancer. World J Gastrointest Oncol. 2014;6(11):430–7.
  7. Araghi M, Soerjomataram I, Bardot A, Ferlay J, Cabasag CJ, Morrison DS, De P, Tervonen H, Walsh PM, Bucher O, Engholm G. Changes in colorectal cancer incidence in seven high-income countries: a population-based study. The lancet Gastroenterology & hepatology. 2019;4(7):511-8.
  8. Pitchumoni CS, Broder A. Epidemiology of colorectal cancer. In: Colorectal Neoplasia and the Colorectal Microbiome. Academic Press: 2020. p. 5-33.
  9. Mattiuzzi C, Sanchis-Gomar F, Lippi G. Concise update on colorectal cancer epidemiology. Annals of translational medicine. 2019;7(21):609.
  10. Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Gastroenterology Review/Przegląd Gastroenterologiczny. 2019;14(2):89-103.
  11. Chauhan K, Shahrokhi M, Huecker MR. Vitamin D. [Updated 2023 Apr 9]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441912/
  12. Pulungan A, Soesanti F, Tridjaja B, Batubara J. Vitamin D insufficiency and its contributing factors in primary school-aged children in Indonesia, a sun-rich country. Annals of Pediatric Endocrinology & Metabolism. 2021;26(2):92.
  13. Mezawa H, Sugiura T, Watanabe M, Norizoe C, Takahashi D, Shimojima A, et al. Serum vitamin D levels and survival of patients with colorectal cancer: post-hoc analysis of a prospective cohort study. BMC cancer. 2010;10:1-8.
  14. Peixoto RD, de Carvalho Oliveira LJ, de Melo Passarini T, Andrade AC, Diniz PH, Prolla G, et al. Vitamin D and colorectal cancer–A practical review of the literature. Cancer Treatment and Research Communications. 2022:100616.
  15. Li FY, Lai MD. Colorectal cancer, one entity or three. Journal of Zhejiang University Science B. 2009;10:219-29.
  16. Maalmi H, Walter V, Jansen L, Boakye D, Schöttker B, Hoffmeister M, et al. Association between blood 25-hydroxyvitamin D levels and survival in colorectal cancer patients: an updated systematic review and meta-analysis. Nutrients. 2018;10(7):89.
  17. Wu G, Xue M, Zhao Y, Han Y, Zhang S, Zhang J, et al. Low circulating 25-hydroxyvitamin D level is associated with increased colorectal cancer mortality: a systematic review and dose–response meta-analysis. Bioscience reports. 2020;40(7):BSR20201008.
  18. Kang W, Lee S, Jeon E, Yun YR, Kim KH, Jang JH. Emerging role of vitamin D in colorectal cancer. World journal of gastrointestinal oncology. 2011;3(8):123.
  19. Bareis P, Kállay E, Bischof MG, Bises G, Hofer H, Pötzi C, et al. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25- dihydroxyvitamin D(3). Exp Cell Res. 2002;276(2):320-7.
  20. Horváth HC, Lakatos P, Kósa JP, Bácsi K, Borka K, Bises G, et al. The candidate oncogene CYP24A1: A potential biomarker for colorectal tumorigenesis. J Histochem Cytochem. 2010;58(3):277-85.
  21. Pálmer HG, Larriba MJ, García JM, Ordóñez-Morán P, Peña C, Peiró S, et al. The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer. Nat Med. 2004;10:917–9.
  22. Larriba MJ, Bonilla F, Munoz A. The transcription factors Snail1 and Snail2 repress vitamin D receptor during colon cancer progression. J Steroid Biochem Mol Biol. 2010;121(1-2):106-9.
  23. Lakemeyer L, Sander S, Wittau M, Henne-Bruns D, Kornmann M, Lemke J. Diagnostic and prognostic value of CEA and CA19-9 in colorectal cancer. Diseases. 2021;9(1):21.
  24. Björkman K, Jalkanen S, Salmi M, Mustonen H, Kaprio T, Kekki H, et al. A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel. Scientific reports. 2021;11(1):4287.
  25. Kankanala VL, Mukkamalla SKR. Carcinoembryonic Antigen. [Updated 2023 Jan 23]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK578172/
  26. Okda TM, Abd-Εlghaffar SK, Katary MA, Abd-Αlhaseeb MM. Chemopreventive and anticancer activities of indomethacin and vitamin D combination on colorectal cancer induced by 1, 2-dimethylhydrazine in rats. Biomedical reports. 2021;14(2):1.
  27. Haidari F, Abiri B, Iravani M, Ahmadi-Angali K, Vafa M. Effects of vitamin D and omega-3 fatty acids Co-supplementation on inflammatory factors and tumor marker CEA in colorectal cancer patients undergoing chemotherapy: a randomized, double-blind, placebo-controlled clinical trial. Nutrition and cancer. 2020;72(6):948-58.
  28. Ghaseminejad-Raeini A, Ghaderi A, Sharafi A, Nematollahi-Sani B, Moossavi M, Derakhshani A, Sarab GA. Immunomodulatory actions of vitamin D in various immune-related disorders: a comprehensive review. Frontiers in Immunology. 2023;14: 950465.
  29. El-Sharkawy A, Malki A. Vitamin D signaling in inflammation and cancer: Molecular mechanisms and therapeutic implications. Molecules. 2020;25(14):3219.
  30. Agusrly C, Sungkar T, Siregar GA. Relationship between staging and carcinoembryonic antigen serum levels in colorectal cancer patients'. Journal of Endocrinology, Tropical Medicine, and Infectious Disease (JETROMI). 2020;2(3):118-23.
  31. Subki A, ButtNS A, Alkahtani AA. CEA and CA19-9 levels and KRAS mutation status as biomarkers for colorectal cancer. Clinical Oncology. 2021;6:1-8.
  32. Topdagi O, Timuroglu A. Evaluation of the relationship between carcinoembryonic antigen and TNM stage in colorectal cancer. The Eurasian journal of medicine. 2018;50(2):96.
  33. Duffy MJ. Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful?. Clinical chemistry. 2001;47(4):624-30.
  34. Mahayasa IPGF, Widiana IK, Adiputra PAT, Sudarsa IW. Vitamin D Receptor (VDR) Apa1 gene polymorphism increasing the risk of breast cancer women in Bali, Indonesia. Bali Med J. 2021;10(1):30-4.
  35. Sindhughosa DA, Wibawa IDN, Mariadi IK, Somayana G. Additional treatment of vitamin D for improvement of insulin resistance in non-alcoholic fatty liver disease patients: a systematic review and meta-analysis. Sci Rep. 2022;12(1):7716.

How to Cite

Razi, K., Putranto, A. S. ., Jeo, W. S. ., Tamba, R. P. ., & Herqutanto. (2023). Analysis of vitamin D supplementation impact on carcinoembryonic antigen (CEA) levels in stage I-III colorectal cancer. Bali Medical Journal, 12(3), 3007–3014. https://doi.org/10.15562/bmj.v12i3.4820
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

HTML
0

Total
0

Share

Search Panel

Khalikul Razi
Google Scholar
Pubmed
BMJ Journal

Agi Satria Putranto
Google Scholar
Pubmed
BMJ Journal

Wifanto Sadityo Jeo
Google Scholar
Pubmed
BMJ Journal

Riana Pauline Tamba
Google Scholar
Pubmed
BMJ Journal

Herqutanto
Google Scholar
Pubmed
BMJ Journal